查找临床试验

已按「白癜风」检索,对应国际通用词 vitiligo

试验不在中国怎么办?

共找到 19 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 00:25,每 5 分钟自动同步
正在招募II 期 / III 期中国有中心NCT07047612

ICP-332 in Subjects With Non-segmental Vitiligo

China

年龄 12 Years – 75 Years

Beijing InnoCare Pharma Tech Co., Ltd.

正在招募II 期中国有中心NCT07533019

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

United States、Belgium、Canada、China、Poland

年龄 18 Years – 75 Years

Eli Lilly and Company

正在招募不适用NCT07136467

A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

Argentina、Canada、Colombia、Czechia、Estonia 等 12 国

年龄 12 Years – 不限

AbbVie

正在招募不适用中国有中心NCT07673640

Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study

China

年龄 12 Years – 不限

ShanShan Li

正在招募III 期中国有中心NCT07682506

A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

China

年龄 12 Years – 75 Years

Minghui Pharmaceutical (Hangzhou) Ltd

正在招募II 期中国有中心NCT07223229

Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

United States、Taiwan

年龄 18 Years – 65 Years

Elixiron Immunotherapeutics (Hong Kong) Ltd.

正在招募II 期中国有中心NCT07108283

A Study of Zasocitinib in Adults With Nonsegmental Vitiligo

United States、Canada、China、France、Italy 等 9 国

年龄 18 Years – 75 Years

Takeda

正在招募I 期中国有中心NCT07554222

Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration

China

年龄 18 Years – 80 Years

Innovent Biologics (Suzhou) Co. Ltd.

正在招募II 期 / III 期中国有中心NCT06719024

Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus

Hong Kong

年龄 18 Years – 85 Years

Hospital Authority, Hong Kong

正在招募不适用中国有中心NCT07187882

Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo

China

年龄 8 Years – 65 Years

Peking University People's Hospital

正在招募II 期中国有中心NCT07437560

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

China

年龄 18 Years – 65 Years

Hudson Biotech

正在招募不适用中国有中心NCT06454461

Efficacy of Upadacitinib After NECS in Vitiligo

China

年龄 18 Years – 60 Years

Jilin University